157 related articles for article (PubMed ID: 35849644)
1. The human cathelicidin hCAP-18 in serum of children with haemato-oncological diseases.
Jackmann N; Englund S; Frisk P; Mäkitie O; Utriainen P; Mörtberg A; Henriques-Normark B; Pütsep K; Harila-Saari A
Br J Haematol; 2022 Sep; 198(6):1023-1031. PubMed ID: 35849644
[TBL] [Abstract][Full Text] [Related]
2. The antimicrobial propeptide hCAP-18 plasma levels in neutropenia of various aetiologies: a prospective study.
Ye Y; Carlsson G; Karlsson-Sjöberg JM; Borregaard N; Modéer TU; Andersson ML; Pütsep KL
Sci Rep; 2015 Jun; 5():11685. PubMed ID: 26119962
[TBL] [Abstract][Full Text] [Related]
3. The blood protein hCAP-18 in neutropenia: An 18-month experience of a new ELISA for clinical use.
Mörtberg A; Pütsep K; Höglund P
Scand J Immunol; 2021 Jul; 94(1):e13037. PubMed ID: 33662157
[TBL] [Abstract][Full Text] [Related]
4. Intracellular cytokine and cathelicidin secretion from monocytes and neutrophils in childhood tuberculosis.
Torun E; Cakir E; Aktas EC; Gedik AH; Deniz G
Pediatr Infect Dis J; 2014 Feb; 33(2):224-6. PubMed ID: 24104956
[TBL] [Abstract][Full Text] [Related]
5. The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils.
Sørensen O; Arnljots K; Cowland JB; Bainton DF; Borregaard N
Blood; 1997 Oct; 90(7):2796-803. PubMed ID: 9326247
[TBL] [Abstract][Full Text] [Related]
6. Marked reduction of LL-37/hCAP-18, an antimicrobial peptide, in patients with acute myeloid leukemia.
An LL; Ma XT; Yang YH; Lin YM; Song YH; Wu KF
Int J Hematol; 2005 Jan; 81(1):45-7. PubMed ID: 15717688
[TBL] [Abstract][Full Text] [Related]
7. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3.
Sørensen OE; Follin P; Johnsen AH; Calafat J; Tjabringa GS; Hiemstra PS; Borregaard N
Blood; 2001 Jun; 97(12):3951-9. PubMed ID: 11389039
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial peptide hCAP-18/LL-37 protein and mRNA expressions in different periodontal diseases.
Türkoğlu O; Kandiloğlu G; Berdeli A; Emingil G; Atilla G
Oral Dis; 2011 Jan; 17(1):60-7. PubMed ID: 20646232
[TBL] [Abstract][Full Text] [Related]
9. An ELISA for hCAP-18, the cathelicidin present in human neutrophils and plasma.
Sørensen O; Cowland JB; Askaa J; Borregaard N
J Immunol Methods; 1997 Aug; 206(1-2):53-9. PubMed ID: 9328568
[TBL] [Abstract][Full Text] [Related]
10. Transient cutaneous adenoviral gene therapy with human host defense peptide hCAP-18/LL-37 is effective for the treatment of burn wound infections.
Jacobsen F; Mittler D; Hirsch T; Gerhards A; Lehnhardt M; Voss B; Steinau HU; Steinstraesser L
Gene Ther; 2005 Oct; 12(20):1494-502. PubMed ID: 15973442
[TBL] [Abstract][Full Text] [Related]
11. Localization of hCAP-18 on the surface of chemoattractant-stimulated human granulocytes: analysis using two novel hCAP-18-specific monoclonal antibodies.
Stie J; Jesaitis AV; Lord CI; Gripentrog JM; Taylor RM; Burritt JB; Jesaitis AJ
J Leukoc Biol; 2007 Jul; 82(1):161-72. PubMed ID: 17400609
[TBL] [Abstract][Full Text] [Related]
12. Isolation of human cationic antimicrobial protein-18 from seminal plasma and its association with prostasomes.
Andersson E; Sørensen OE; Frohm B; Borregaard N; Egesten A; Malm J
Hum Reprod; 2002 Oct; 17(10):2529-34. PubMed ID: 12351523
[TBL] [Abstract][Full Text] [Related]
13. The human antibacterial cathelicidin, hCAP-18, is bound to lipoproteins in plasma.
Sørensen O; Bratt T; Johnsen AH; Madsen MT; Borregaard N
J Biol Chem; 1999 Aug; 274(32):22445-51. PubMed ID: 10428818
[TBL] [Abstract][Full Text] [Related]
14. Sorting of neutrophil-specific granule protein human cathelicidin, hCAP-18, when constitutively expressed in myeloid cells.
Bülow E; Bengtsson N; Calafat J; Gullberg U; Olsson I
J Leukoc Biol; 2002 Jul; 72(1):147-53. PubMed ID: 12101274
[TBL] [Abstract][Full Text] [Related]
15. Interactions between neutrophil-derived antimicrobial peptides and airway epithelial cells.
van Wetering S; Tjabringa GS; Hiemstra PS
J Leukoc Biol; 2005 Apr; 77(4):444-50. PubMed ID: 15591123
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary defense and the human cathelicidin hCAP-18/LL-37.
Fahy RJ; Wewers MD
Immunol Res; 2005; 31(2):75-89. PubMed ID: 15778507
[TBL] [Abstract][Full Text] [Related]
17. The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cells.
von Haussen J; Koczulla R; Shaykhiev R; Herr C; Pinkenburg O; Reimer D; Wiewrodt R; Biesterfeld S; Aigner A; Czubayko F; Bals R
Lung Cancer; 2008 Jan; 59(1):12-23. PubMed ID: 17764778
[TBL] [Abstract][Full Text] [Related]
18. Ovarian cancers overexpress the antimicrobial protein hCAP-18 and its derivative LL-37 increases ovarian cancer cell proliferation and invasion.
Coffelt SB; Waterman RS; Florez L; Höner zu Bentrup K; Zwezdaryk KJ; Tomchuck SL; LaMarca HL; Danka ES; Morris CA; Scandurro AB
Int J Cancer; 2008 Mar; 122(5):1030-9. PubMed ID: 17960624
[TBL] [Abstract][Full Text] [Related]
19. The antimicrobial peptide human cationic antimicrobial protein-18/cathelicidin LL-37 as a putative growth factor for malignant melanoma.
Kim JE; Kim HJ; Choi JM; Lee KH; Kim TY; Cho BK; Jung JY; Chung KY; Cho D; Park HJ
Br J Dermatol; 2010 Nov; 163(5):959-67. PubMed ID: 20977442
[TBL] [Abstract][Full Text] [Related]
20. The human cathelicidin hCAP-18.
Sørensen OE
Dan Med Bull; 2005 Feb; 52(1):1-10. PubMed ID: 16009068
[No Abstract] [Full Text] [Related]
[Next] [New Search]
